{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T09:54:24Z","timestamp":1738490064030,"version":"3.35.0"},"reference-count":28,"publisher":"Japan Surgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Case Rep"],"published-print":{"date-parts":[[2025]]},"DOI":"10.70352\/scrj.cr.24-0082","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T22:16:35Z","timestamp":1738275395000},"page":"n\/a","source":"Crossref","is-referenced-by-count":0,"title":["Breast Cancer with a Newly Diagnosed Variant in the <i>PTEN<\/i> Gene: A Case Report"],"prefix":"10.70352","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9163-5017","authenticated-orcid":false,"given":"Yuka","family":"Maeda","sequence":"first","affiliation":[{"name":"Department of Surgery, School of Medicine, Teikyo University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiko","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, Teikyo University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayana","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, Teikyo University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, Teikyo University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Jinno","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, Teikyo University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"51119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Pilarski R, Burt R, Kohlman W, et al. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl Cancer Inst 2013; 105: 1607\u201316.","DOI":"10.1093\/jnci\/djt277"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Tan MH, Mester JL, Ngeow J, et al. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res 2012; 18: 400\u20137.","DOI":"10.1158\/1078-0432.CCR-11-2283"},{"key":"3","unstructured":"3) NCCN guidelines. Genetic\/familial high-risk assessment: breast and ovarian, version 3. 2019, 2019. https:\/\/www2.tri-kobe.org\/nccn\/guideline\/gynecological\/english\/genetic_familial.pdf#search=%27NCCN+guidline%2C+hereditary+and+familial+breast+and+ovarian%27."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Bubien V, Bonnet F, Brouste V, et al. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet 2013; 50: 255\u201363.","DOI":"10.1136\/jmedgenet-2012-101339"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Teramae S, Muguruma N, Okamoto K, et al. Cancer risk and genotype-phenotype correlation in Japanese patients with Cowden syndrome. Int J Clin Oncol 2022; 27: 639\u201347.","DOI":"10.1007\/s10147-022-02116-w"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Tan MH, Mester J, Peterson C, et al. A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. Am J Hum Genet 2011; 88: 42\u201356.","DOI":"10.1016\/j.ajhg.2010.11.013"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Ngeow J, Stanuch K, Mester JL, et al. Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations. J Clin Oncol 2014; 32: 1818\u201324.","DOI":"10.1200\/JCO.2013.53.6656"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Mester J, Eng C. When overgrowth bumps into cancer: the PTEN-opathies. Am J Med Genet C Semin Med Genet 2013; 163: 114\u201321.","DOI":"10.1002\/ajmg.c.31364"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Zbuk KM, Eng C. Cancer phenomics: RET and PTEN as illustrative models. Nat Rev Cancer 2007; 7: 35\u201345.","DOI":"10.1038\/nrc2037"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Nieuwenhuis MH, Kets CM, Murphy-Ryan M, et al. Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome. Fam Cancer 2014; 13: 57\u201363.","DOI":"10.1007\/s10689-013-9674-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Leslie NR, Longy M. Inherited PTEN mutations and the prediction of phenotype. Semin Cell Dev Biol 2016; 52: 30\u20138.","DOI":"10.1016\/j.semcdb.2016.01.030"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490: 61\u201370.","DOI":"10.1038\/nature11412"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Pradella LM, Evangelisti C, Ligorio C, et al. A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer. BMC Cancer 2014; 14: 70.","DOI":"10.1186\/1471-2407-14-70"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Nara M, Ishida N, Hagio K, et al. Two cases of breast cancer in juvenile patients in their thirties with pten hamartoma tumor syndrome. J Jpn Surg Assoc 2017; 78: 2624\u20138. (in Japanese)","DOI":"10.3919\/jjsa.78.2624"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Chandhanayingyong MC, Bernthal NM, Ungarreevittaya P, et al. Ewing sarcoma in a patient with Cowden syndrome. J Natl Compr Canc Netw 2015; 13: 1310\u20134.","DOI":"10.6004\/jnccn.2015.0161"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Gosein MA, Narinesingh D, Nixon CA-AC, et al. Multi-organ benign and malignant tumors: recognizing Cowden syndrome: a case report and review of the literature. BMC Res Notes 2016; 9: 388.","DOI":"10.1186\/s13104-016-2195-z"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Walsh S, Carter M, Tubridy N, et al. Lhermitte-Duclos and Cowden diseases: breast cancer as an unusual initial presentation of these overlapping conditions. BMJ Case Rep 2011; 2011: bcr0820114730.","DOI":"10.1136\/bcr.08.2011.4730"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Won HS, Chang ED, Na SJ, et al. PTEN mutation identified in patient diagnosed with simultaneous multiple cancers. Cancer Res Treat 2019; 51: 402\u20137.","DOI":"10.4143\/crt.2017.579"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Fackenthal JD, Marsh DJ, Richardson AL, et al. Male breast cancer in Cowden syndrome patients with germline PTEN mutations. J Med Genet 2001; 38: 159\u201364.","DOI":"10.1136\/jmg.38.3.159"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Sueta A, Takeno M, Goto-Yamaguchi L, et al. A progressive and refractory case of breast cancer with Cowden syndrome. World J Surg Oncol 2022; 20: 279.","DOI":"10.1186\/s12957-022-02745-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Peir\u00f3 G, Adrover E, Guijarro J, et al. Synchronous bilateral breast carcinoma in a patient with Cowden syndrome: a case report with morphologic, immunohistochemical and genetic analysis. Breast J 2010; 16: 77\u201381.","DOI":"10.1111\/j.1524-4741.2009.00846.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Sabat\u00e9 JM, G\u00f3mez A, Torrubia S, et al. Evaluation of breast involvement in relation to Cowden syndrome: a radiological and clinicopathological study of patients with PTEN germ-line mutations. Eur Radiol 2006; 16: 702\u20136.","DOI":"10.1007\/s00330-005-2877-8"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Nelen MR, Padberg GW, Peeters EA, et al. Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet 1996; 13: 114\u20136.","DOI":"10.1038\/ng0596-114"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Pilarski R, Stephens JA, Noss R, et al. Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features. J Med Genet 2011; 48: 505\u201312.","DOI":"10.1136\/jmg.2011.088807"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Stambolic V, Suzuki A, de la Pompa JL, et al. Negative regulation of PKB\/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998; 95: 29\u201339.","DOI":"10.1016\/S0092-8674(00)81780-8"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Williams AD, LaRoy J, Le T, et al. Clinical challenges in breast care for patients with PTEN pathogenic variants: a case series and literature review. Surg Oncol Insight 2024; 1: 100016.","DOI":"10.1016\/j.soi.2024.100016"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Riegert-Johnson DL, Gleeson FC, Roberts M, et al. Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients. Hered Cancer Clin Pract 2010; 8: 6.","DOI":"10.1186\/1897-4287-8-6"},{"key":"28","unstructured":"28) NCCN clinical practice guidelines in oncology. Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 3. 2024, 2024. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=2&id=1503."}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/11\/1\/11_cr.24-0082\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T05:19:42Z","timestamp":1738387182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/11\/1\/11_cr.24-0082\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.70352\/scrj.cr.24-0082","relation":{},"ISSN":["2198-7793"],"issn-type":[{"type":"electronic","value":"2198-7793"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"cr.24-0082"}}